Adverse drug reaction of oseltamivir in pediatric patients

ABSTRACT

I read the recent publication on the adverse drug reaction of oseltamivir in pediatric patients with a great interest.[1] Dalvi et al. concluded that “oseltamivir is well tolerated in Indian children with suspected or confirmed H1N1 influenza.”[1] There are some concerns about this work. First, as Dalvi et al. noted, the few subjects in this work might not allow this strong conclusion. The studied populations are not well stratified and there is no consideration of the underlying diseases that might be problematic while using oseltamivir. The special situations such as cases with occult glucose-6-phophate dehydrogenase deficiency disorders or hemoglobinopathies should be further studied for the safety of oseltamivir usage.

KEYWORDS

• Correspondence

Showing references and in-text citations exactly as published.

• DOI10.4103/0976-500X.92507Copy

RELATED ARTICLES

Matched on section and article type within this issue of JPP.

• Article · VOLUME 3, ISSUE 1An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programmeDick B. S. Brashier, Sushil Sharma · pp. 74–75CorrespondenceSame type: Article
• Article · VOLUME 3, ISSUE 1Assessing citations with Google Scholar: A new featureMueen Ahmed K. · pp. 75–76CorrespondenceSame type: Article
• Article · VOLUME 3, ISSUE 1Prophylactic ocular hypotensives before Nd:YAG laser posterior capsulotomyAshok K. Dubey · pp. 79–80CorrespondenceSame type: Article
• Article · VOLUME 3, ISSUE 1Belatacept: Good, but not good enough?Sreejith Parameswaran, R. P. Swaminathan · pp. 82–83CorrespondenceSame type: Article